AzTrials
AzTrials

Cholesterol (Total and HDL)NCT07703202

Step-Aerobics Versus Core Exercise for Non-HDL Cholesterol Reduction in Sedentary/Obesity Women

A study testing Intervention 1: Step-Aerobics Program and Intervention 2: Core Exercise Program in people with Cholesterol (Total and HDL) and Exercise, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigated the effects of a step-aerobics program versus a core exercise program on serum non-HDL-C levels and other cardiometabolic parameters in sedentary women with overweight/obesity. Read more about this study

Who is it for?
Ages 25 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Cholesterol (Total and HDL), Exercise
What is being tested?
Intervention 1: Step-Aerobics Program and Intervention 2: Core Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2026to 1 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female sex
  • Aged 25-45 years
  • Sedentary lifestyle (< 150 minutes/week of moderate-intensity activity for preceding 6 months)
  • Overweight or Class I Obesity (BMI 25.0-34.9 kg/m²) per WHO criteria
  • Willingness to participate in a 24-week supervised exercise program with written informed consent

Who cannot join

  • Diagnosed cardiovascular disease (CVD)
  • Uncontrolled hypertension (SBP >140 or DBP >90 mmHg)
  • Diabetes mellitus (Type 1 or 2)
  • Current/past lipid-lowering or antihypertensive medications (within 6 months)
  • Active smoking
  • Pregnancy or lactation
  • Musculoskeletal/orthopedic conditions preventing safe exercise participation
  • Structured exercise program participation within past 6 months

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Mugla Sitki Kocman University

    Menteşe, Muğla, 48050

Other trials in Turkey (Türkiye)

About this study

Official title: Step-Aerobics Versus Core Exercise for Non-HDL Cholesterol Reduction in Sedentary Women With Overweight/Obesity

This study investigated the effects of a step-aerobics program versus a core exercise program on serum non-HDL-C levels and other cardiometabolic parameters in sedentary women with overweight/obesity.

Read the detailed description

Non-high-density lipoprotein cholesterol (non-HDL-C) is a key predictor of cardiovascular disease (CVD), yet the comparative effects of different exercise modalities on this marker, particularly in high-risk populations, are not fully understood.

This study will investigate the effects of a step-aerobics program versus a core exercise program on serum non-HDL-C levels and other cardiometabolic parameters in sedentary women with overweight/obesity.

Study Design Overview Study Type: Randomized Controlled Trial Target Enrollment: Forty-five sedentary women with overweight/obesity Study Duration: 24 weeks Supervision: All exercise sessions will be professionally supervised

Being tested
Intervention 1: Step-Aerobics Program, Intervention 2: Core Exercise Program
Keywords
exercise, everweight, obesity, women, cholesterol
Medical subject headings
Motor Activity, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention 1: Step-Aerobics ProgramOther

    Exercise Protocol

    Total Session Duration: 60 minutes

    Session Structure:

    Warm-up Phase (10 minutes)

    Low-intensity aerobic movements designed to slowly raise heart rate and prepare the cardiovascular system for more vigorous exercise. This phase consisted of:

    • Low stepping movements
    • Arm circles
    • Dynamic stretching exercises

    Main Exercise Phase (40 minutes)

    Aerobic-step exercise routines performed on adjustable step platforms. The protocol included:

    • Step Height: Individualized according to participant fitness level and progressed incrementally during the intervention

    •

    Exercise Components:

    • Simple step-ups
    • Lateral steps
    • Knee lifts
    • Complex choreographed movement patterns incorporating both lower and upper body movements
    • Music: Suitable tempo music was used to help maintain rhythm and motivation

    Cool-down Phase (10 minutes)

    Progressive decrease in exercise intensity coupled with:

    • Stretching exercises
    • Heart rate recovery period
    • Breathing exercises
  • Intervention 2: Core Exercise ProgramOther

    Exercise Protocol

    Total Session Duration: 60 minutes

    Session Structure:

    Warm-up Phase (10 minutes)

    Simple aerobic movements with focus on core engagement and spinal mobility. This phase involved:

    • Marching in place
    • Slow torso rotations
    • Preparatory core engagement exercises

    Main Exercise Phase (40 minutes)

    Strength and stability exercises targeting the core and integrating aerobic movements. The protocol included:

    • Planks (various variations)
    • Modified crunches
    • Bridge exercises
    • Stability ball exercises
    • Pilates-inspired movements
    • Functional core strengthening exercises
    • Aerobic Element: Continuous movement patterns and circuit-style training to keep heart rate within the desired zone

    Cool-down Phase (10 minutes)

    Progressive decrease in exercise intensity coupled with:

    • Stretching exercises (particularly core and lower back)
    • Heart rate recovery period
    • Breathing exercises and relaxation techniques
Study groups in NCT07703202
Study groupRoleWhat they receive
step-aerobics groupActive comparatorThe aerobic-step exercise training protocol included methodically planned 60-minute training sessions with the following components: Warm-up Phase (10 minutes): Low-intensity aerobic movements that are intended to slowly raise heart rate and ready the cardiovascular system for more vigorous exercise. This phase consisted of low stepping movements, arm circles, and dynamic stretching exercises. Main Exercise Phase (40 minutes): Aerobic-step exercise routines done on adjustable step platforms.Step height was individualized according to participant fitness level and progressed incrementally during the course of the intervention. Exercises consisted of simple step-ups, lateral steps, knee lifts, and complex choreographed movement patterns incorporating both lower and upper body movements. Music with suitable tempo was used to help maintain rhythm and motivation. Cool-down Phase (10 minutes): Progressive decrease in the intensity of exercise coupled
Receives: Other: Intervention 1: Step-Aerobics Program
core exercise groupActive comparatorWarm-up Phase (10 minutes): Simple aerobic movements akin to the step group but with focus on core engagement and spinal mobility. This phase involved marching in place, slow torso rotations, and preparatory core engagement exercises. Main Exercise Phase (40 minutes): Strength and stability exercises targeting the core and integrating aerobic movements. Planks, modified crunches, bridge exercises, stability ball exercises, Pilates160 inspired movements, and functional core strengthening exercises were included in this phase. The aerobic element was preserved by using continuous movement patterns and circuit-style training to keep heart rate within the desired zone.
Receives: Other: Intervention 2: Core Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serum non-HDL-C levels (measured in mg/dL via standard lipid panel analysis)

    To analyze the effects of a 24-week supervised step aerobics and core exercise program on serum non-HDL-C levels (measured in mg/dL via standard lipid panel analysis) in overweight or obese, sedentary individuals.

    Measured: 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study start1 Jan 2026
  3. Primary completion1 Jan 2026
  4. Study completion1 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two groups with a step aerobics group or a core exercise group
Masking
Single blind
Who is masked
Investigator
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07703202
Sponsor's protocol ID
muglaSKU-CRD-OC-04
Status last verified
Jul 2026
First submitted
4 Jul 2026
Last updated
14 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention 1: Step-Aerobics Program and Intervention 2: Core Exercise Program in people with Cholesterol (Total and HDL) and Exercise, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serum non-HDL-C levels (measured in mg/dL via standard lipid panel analysis) (time frame: 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in